Clinical significance of fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography in the follow-up of colorectal cancer: searching off approaches increasing specificity for detection of recurrence
This article is distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Hammond K, Margolin DA. The role of postoperative surveillance in colorectal cancer. Clin Colon Rectal Surg 2007; 20: 249-54. 10.1055/s-2007-98486920011206HammondKMargolinDA.The role of postoperative surveillance in colorectal cancerClin Colon Rectal Surg2007202495410.1055/s-2007-984869Open DOISearch in Google Scholar
Gade M, Kubik M, Fisker RV, Thorlacius-Ussing O, Petersen LJ. Diagnostic value of (18)F-FDG PET/CT as first choice in the detection of recurrent colorectal cancer due to rising CEA. Cancer Imaging 2015; 15: 11. 10.1186/s40644-015-0048-y26263901GadeMKubikMFiskerRVThorlacius-UssingOPetersenLJ.Diagnostic value of (18)F-FDG PET/CT as first choice in the detection of recurrent colorectal cancer due to rising CEACancer Imaging2015151110.1186/s40644-015-0048-yOpen DOISearch in Google Scholar
Laurens ST, Oyen WJ. Impact of fluorodeoxyglucose PET/Computed Tomography on the management of patients with colorectal cancer. PET Clin 2015; 10: 345-60. 10.1016/j.cpet.2015.03.00726099671LaurensSTOyenWJ.Impact of fluorodeoxyglucose PET/Computed Tomography on the management of patients with colorectal cancerPET Clin2015103456010.1016/j.cpet.2015.03.007Open DOISearch in Google Scholar
Chen CH, Hsieh MC, Lai CC, Yeh CY, Chen JS, Hsieh PS, et al. Lead time of carcinoembryonic antigen elevation in the postoperative follow-up of colorectal cancer did not affect the survival rate after recurrence. Int J Colorectal Dis 2010; 25: 567-71. 10.1007/s00384-010-0889-620162425ChenCHHsiehMCLaiCCYehCYChenJSHsiehPSLead time of carcinoembryonic antigen elevation in the postoperative follow-up of colorectal cancer did not affect the survival rate after recurrenceInt J Colorectal Dis2010255677110.1007/s00384-010-0889-6Open DOISearch in Google Scholar
Chiaravalloti A, Fiorentini A, Palombo E, Rinino D, Lacanfora A, Danieli R, et al. Evaluation of recurrent disease in the re-staging of colorectal cancer by 18F-FDG PET/CT: Use of CEA and CA 19-9 in patient selection. Oncol Lett 2016; 12: 4209-13. 10.3892/ol.2016.514327895793ChiaravallotiAFiorentiniAPalomboERininoDLacanforaADanieliREvaluation of recurrent disease in the re-staging of colorectal cancer by 18F-FDG PET/CT: Use of CEA and CA 19-9 in patient selectionOncol Lett20161242091310.3892/ol.2016.5143Open DOISearch in Google Scholar
Van de Velde CJ, Boelens PG, Borras JM, Coebergh JW, Cervantes A, Blomqvist L, et al. EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum. Eur J Cancer 2014; 50: 1.e1-34. 10.1016/j.ejca.2013.06.048Van de VeldeCJBoelensPGBorrasJMCoeberghJWCervantesABlomqvistLEURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectumEur J Cancer2014501e13410.1016/j.ejca.2013.06.048Open DOISearch in Google Scholar
Tan E, Gouvas N, Nicholls RJ, Ziprin P, Xynos E, Tekkis PP. Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancer. Surg Oncol 2009; 18: 15-24. 10.1016/j.suronc.2008.05.00818619834TanEGouvasNNichollsRJZiprinPXynosETekkisPP.Diagnostic precision of carcinoembryonic antigen in the detection of recurrence of colorectal cancerSurg Oncol200918152410.1016/j.suronc.2008.05.008Open DOISearch in Google Scholar
Filella X, Molina R, Piqué JM, Garcia-Valdecasas JC, Grau JJ, Novell F, et al. Use of CA 19-9 in the early detection of recurrences in colorectal cancer: Comparison with CEA. Tumour Biol 1994; 15: 1-6.10.1159/0002178678146525FilellaXMolinaRPiquéJMGarcia-ValdecasasJCGrauJJNovellFUse of CA 19-9 in the early detection of recurrences in colorectal cancer: Comparison with CEATumour Biol19941516Open DOISearch in Google Scholar
Panagiotidis E, Datseris IE, Rondogianni P, Vlontzou E, Skilakaki M, Exarhos D, et al. Does CEA and CA 19-9 combined increase the likelihood of 18F-FDG in detecting recurrence in colorectal patients with negative CeCT? Nucl Med Commun 2014; 35: 598-605. 10.1097/MNM.000000000000010724681767PanagiotidisEDatserisIERondogianniPVlontzouESkilakakiMExarhosDDoes CEA and CA 19-9 combined increase the likelihood of 18F-FDG in detecting recurrence in colorectal patients with negative CeCT?Nucl Med Commun20143559860510.1097/MNM.0000000000000107Open DOISearch in Google Scholar
Sanli Y, Kuyumcu S, Ozkan ZG, Kilic L, Balik E, Turkmen C, et al. The utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levels. Ann Nucl Med 2012; 26: 551-8. 10.1007/s12149-012-0609-022644560SanliYKuyumcuSOzkanZGKilicLBalikETurkmenCThe utility of FDG-PET/CT as an effective tool for detecting recurrent colorectal cancer regardless of serum CEA levelsAnn Nucl Med201226551810.1007/s12149-012-0609-0Open DOISearch in Google Scholar
Zhuang H, Alavi A. 18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammation. Semin Nucl Med 2002; 32: 47-59. 10.1053/snuc.2002.2927811839069ZhuangHAlaviA.18-Fluorodeoxyglucose positron emission tomographic imaging in the detection and monitoring of infection and inflammationSemin Nucl Med200232475910.1053/snuc.2002.29278Open DOISearch in Google Scholar
Choi H, Yoon HJ, Kim TS, Oh JH, Kim DY, Kim SK. Voxel-based dual-time 18F-FDG parametric imaging for rectal cancer: differentiation of residual tumor from postchemoradiotherapy changes. Nucl Med Commun 2013; 34: 1166-73. 10.1097/MNM.000000000000000224128896ChoiHYoonHJKimTSOhJHKimDYKimSK.Voxel-based dual-time 18F-FDG parametric imaging for rectal cancer: differentiation of residual tumor from postchemoradiotherapy changesNucl Med Commun20133411667310.1097/MNM.0000000000000002Open DOISearch in Google Scholar
Chan K, Welch S, Walker-Dilks C, Raifu A. Ontario provincial Gastrointestinal Disease Site Group. Evidence-based guideline recommendations on the use of positron emission tomography imaging in colorectal cancer. Clin Oncol (R Coll Radiol) 2012; 24: 232-49. 10.1016/j.clon.2011.11.008ChanKWelchSWalker-DilksCRaifuA.Ontario provincial Gastrointestinal Disease Site Group. Evidence-based guideline recommendations on the use of positron emission tomography imaging in colorectal cancerClin Oncol (R Coll Radiol)2012242324910.1016/j.clon.2011.11.008Open DOISearch in Google Scholar
Basu S, Alavi A. Partial volume correction of standardized uptake values and the dual time point in FDG-PET imaging: should these be routinely employed in assessing patients with cancer? Eur J Nucl Med Mol Imaging 2007; 34: 1527-9. 10.1007/s00259-007-0467-517522857BasuSAlaviA.Partial volume correction of standardized uptake values and the dual time point in FDG-PET imaging: should these be routinely employed in assessing patients with cancer?Eur J Nucl Med Mol Imaging2007341527910.1007/s00259-007-0467-5Open DOISearch in Google Scholar
Bowne WB, Lee B, Wong WD, Ben-Porat L, Shia J, Cohen AM, et al. Operative salvage for locoregional recurrent colon cancer after curative resection: An analysis of 100 cases. Dis Colon Rectum 2005; 48: 897-909. 10.1007/s10350-004-0881-815785892BowneWBLeeBWongWDBen-PoratLShiaJCohenAMOperative salvage for locoregional recurrent colon cancer after curative resection: An analysis of 100 casesDis Colon Rectum20054889790910.1007/s10350-004-0881-8Open DOISearch in Google Scholar
Sobhani I, Tiret E, Lebtahi R, Aparicio T, Itti E, Montravers F, et al. Early detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancer. Br J Cancer 2008; 98: 875-80. 10.1038/sj.bjc.660426318301402SobhaniITiretELebtahiRAparicioTIttiEMontraversFEarly detection of recurrence by 18FDG-PET in the follow-up of patients with colorectal cancerBr J Cancer2008988758010.1038/sj.bjc.6604263Open DOISearch in Google Scholar
Scott AM, Gunawardana DH, Kelley B, Stuckey JG, Byrne AJ, Ramshaw JE, et al. PET changes management and improves prognostic stratification in patients with recurrent colorectal cancer: results of a multicenter prospective study. J Nucl Med 2008; 49: 1451-7. 10.2967/jnumed.108.05161518703607ScottAMGunawardanaDHKelleyBStuckeyJGByrneAJRamshawJEPET changes management and improves prognostic stratification in patients with recurrent colorectal cancer: results of a multicenter prospective studyJ Nucl Med2008491451710.2967/jnumed.108.051615Open DOISearch in Google Scholar
Lu YY, Chen JH, Chien CR, Chen WT, Tsai SC, Lin WY, et al. Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: a systematic review and meta-analysis. Int J Colorectal Dis 2013; 28: 1039-47. 10.1007/s00384-013-1659-zLuYYChenJHChienCRChenWTTsaiSCLinWYUse of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: a systematic review and meta-analysisInt J Colorectal Dis20132810394710.1007/s00384-013-1659-zOpen DOISearch in Google Scholar
Maas M, Rutten IJ, Nelemans PJ, Lambregts DM, Cappendijk VC, Beets GL, et al. What is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis: imaging for recurrent colorectal cancer. Eur J Nucl Med Mol Imaging 2011; 38: 1560-71. 10.1007/s00259-011-1785-121468765MaasMRuttenIJNelemansPJLambregtsDMCappendijkVCBeetsGLWhat is the most accurate whole-body imaging modality for assessment of local and distant recurrent disease in colorectal cancer? A meta-analysis: imaging for recurrent colorectal cancerEur J Nucl Med Mol Imaging20113815607110.1007/s00259-011-1785-1Open DOISearch in Google Scholar
Shmidt E, Nehra V, Lowe V, Oxentenko AS. Clinical significance of incidental [18F]FDG uptake in the gastrointestinal tract on PET/CT imaging: a retrospective cohort study. BMC Gastroenterol 2016; 16: 125. 10.1186/s12876-016-0545-x27716085ShmidtENehraVLoweVOxentenkoAS.Clinical significance of incidental [18F]FDG uptake in the gastrointestinal tract on PET/CT imaging: a retrospective cohort studyBMC Gastroenterol20161612510.1186/s12876-016-0545-xOpen DOISearch in Google Scholar
Abdel-Nabi H, Doerr RJ, Lamonica DM, Cronin VR, Galantowicz PJ, Carbone GM, et al. Staging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findings. Radiology 1998; 206: 755-60. 10.1148/radiology.206.3.94944979494497Abdel-NabiHDoerrRJLamonicaDMCroninVRGalantowiczPJCarboneGMStaging of primary colorectal carcinomas with fluorine-18 fluorodeoxyglucose whole-body PET: correlation with histopathologic and CT findingsRadiology19982067556010.1148/radiology.206.3.9494497Open DOISearch in Google Scholar
Prieto E, Marti-Climent JM, Dominguez-Prado I, Garrastachu P, Díez-Valle R, Tejada S, et al. Voxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineation. J Nucl Med 2011; 52: 865-72. 10.2967/jnumed.110.08532421571807PrietoEMarti-ClimentJMDominguez-PradoIGarrastachuPDíez-ValleRTejadaSVoxel-based analysis of dual-time-point 18F-FDG PET images for brain tumor identification and delineationJ Nucl Med2011528657210.2967/jnumed.110.085324Open DOISearch in Google Scholar
Schillaci O. Use of dual-point fluorodeoxyglucose imaging to enhance sensitivity and specificity. Semin Nucl Med 2012; 42: 267-80. 10.1053/j.semnuclmed.2012.02.00322681676SchillaciO.Use of dual-point fluorodeoxyglucose imaging to enhance sensitivity and specificitySemin Nucl Med2012422678010.1053/j.semnuclmed.2012.02.003Open DOISearch in Google Scholar
Miyake KK, Nakamoto Y, Togashi K. Dual-time-point 18F-FDG PET/CT in patients with colorectal cancer: clinical value of early delayed scanning. Ann Nucl Med 2012; 26: 492-500. 10.1007/s12149-012-0599-y22492392MiyakeKKNakamotoYTogashiK.Dual-time-point 18F-FDG PET/CT in patients with colorectal cancer: clinical value of early delayed scanningAnn Nucl Med20122649250010.1007/s12149-012-0599-yOpen DOISearch in Google Scholar
Yoon HJ, Kim SK, Kim TS, et al. New application of dual time point 18F-FDG PET/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancer. Clin Nucl Med 2013; 38: 7-12. 10.1097/RLU.0b013e3182639a5823242038YoonHJKimSKKimTSNew application of dual time point 18F-FDG PET/CT in the evaluation of neoadjuvant chemoradiation response of locally advanced rectal cancerClin Nucl Med20133871210.1097/RLU.0b013e3182639a58Open DOISearch in Google Scholar
Marcus C, Wray R, Taghipour M, Marashdeh W, Ahn SJ, Mena E, et al. Journal club: Value of quantitative FDG PET/CT volumetric biomarkers in recurrent colorectal cancer patient survival. AJR Am J Roentgenol 2016; 207: 257-65. 10.2214/AJR.15.1580627447341MarcusCWrayRTaghipourMMarashdehWAhnSJMenaEJournal club: Value of quantitative FDG PET/CT volumetric biomarkers in recurrent colorectal cancer patient survivalAJR Am J Roentgenol20162072576510.2214/AJR.15.15806Open DOISearch in Google Scholar
Shamim SA, Kumar R, Halanaik D, Shandal V, Reddy RM, Bal CS, et al. Role of FDG-PET/CT in detection of recurrent disease in colorectal cancer. Nucl Med Commun 2010; 31: 590-6. 10.1097/MNM.0b013e328338a12020300042ShamimSAKumarRHalanaikDShandalVReddyRMBalCSRole of FDG-PET/CT in detection of recurrent disease in colorectal cancerNucl Med Commun201031590610.1097/MNM.0b013e328338a120Open DOISearch in Google Scholar
Giacomobono S, Gallicchio R, Capacchione D, Nardelli A, Gattozzi D, Lettini G, et al. F-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancer. Int J Colorectal Dis 2013; 28: 1699-705. 10.1007/s00384-013-1747-0.23846517GiacomobonoSGallicchioRCapacchioneDNardelliAGattozziDLettiniGF-18 FDG PET/CT in the assessment of patients with unexplained CEA rise after surgical curative resection for colorectal cancerInt J Colorectal Dis201328169970510.1007/s00384-013-1747-0Open DOISearch in Google Scholar
Arslan N, Tuncel M, Kuzhan O, Alagoz E, Budakoglu B, Ozet A, et al. Evaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-D-glucose with positron emission tomography in patients with small cell lung cancer. Ann Nucl Med 2011; 25: 406-13. 10.1007/s12149-011-0478-y21409347ArslanNTuncelMKuzhanOAlagozEBudakogluBOzetAEvaluation of outcome prediction and disease extension by quantitative 2-deoxy-2-[18F] fluoro-D-glucose with positron emission tomography in patients with small cell lung cancerAnn Nucl Med2011254061310.1007/s12149-011-0478-yOpen DOISearch in Google Scholar
Caglar M, Yener C, Karabulut E. Value of CT, FDG PET-CT and serum tumor markers in staging recurrent colorectal cancer. Int J Comput Assist Radiol Surg 2015; 10: 993-1002. 10.1007/s11548-014-1115-825213271CaglarMYenerCKarabulutE.Value of CT FDG PET-CT and serum tumor markers in staging recurrent colorectal cancerInt J Comput Assist Radiol Surg201510993100210.1007/s11548-014-1115-8Open DOISearch in Google Scholar
